Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.66 |
| ▸ | CA2 | P00918 | 4/20 | 0.66 |
| ▸ | CA12 | O43570 | 3/20 | 0.66 |
| ▸ | CA9 | Q16790 | 3/20 | 0.66 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.66 |
| ▸ | CA7 | P43166 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | CASP3 | P42574 | 1/20 | 0.48 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.48 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30251598 | 0.92 | TSHR (0.64) | CA1CA2CA12CA9CA14 | |
| SCHEMBL866718 | 0.92 | TSHR (0.64) | CA1CA2CA12CA9CA14 | |
| SCHEMBL4248683 | 0.91 | CA1 (0.61) | CA1CA2CA12CA9CA14 | |
| SCHEMBL28823597 | 0.91 | CA1 (0.75) | CA1CA2CA12CA9CA14 | |
| SCHEMBL3297654 | 0.91 | CA1 (0.57) | CA1CA2CA12CA9CA14 | |
| SCHEMBL1765758 | 0.91 | CA1 (0.57) | CA1CA2CA12CA9CA14 | |
| SCHEMBL6533202 | 0.88 | CA1 (0.56) | CA1CA2CA12CA9CA14 | |
| SCHEMBL14487959 | 0.87 | CA1 (0.59) | CA1CA2CA12CA9CA14 | |
| SCHEMBL2515882 | 0.86 | CA1 (0.54) | CA1CA2CA12CA9CA14 | |
| SCHEMBL30251393 | 0.86 | CA1 (0.54) | CA1CA2CA12CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8247687-B2 | Photoelectric conversion element and solar cell | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2012-08-21 | — | — | US | disclosed |
| US-8247687-B2 | Photoelectric conversion element and solar cell | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2012-08-21 | — | — | US | disclosed |
| US-20090250115-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND SOLAR CELL | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2009-10-08 | — | — | US | disclosed |
| US-20090250115-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND SOLAR CELL | KONICA MINOLTA BUSINESS TECHNOLOGIES, INC. (JP) | 2009-10-08 | — | — | US | disclosed |
| US-7485742-B2 | Non-glycosidic and non-peptidic inhibitors of selectin, and the use thereof | Johannes Gutenberg-Universität Mainz (DE) | 2009-02-03 | — | — | US | disclosed |
| US-7485742-B2 | Non-glycosidic and non-peptidic inhibitors of selectin, and the use thereof | Johannes Gutenberg-Universität Mainz (DE) | 2009-02-03 | — | — | US | disclosed |
| US-20070276036-A1 | Non-Glycosidic and Non-Peptidic Select Inhibitors, and the Use Thereof | JOHANNES GUTENBERG-UNIVERSITAT MAINZ (DE) | 2007-11-29 | — | — | US | disclosed |
| US-20070276036-A1 | Non-Glycosidic and Non-Peptidic Select Inhibitors, and the Use Thereof | JOHANNES GUTENBERG-UNIVERSITAT MAINZ (DE) | 2007-11-29 | — | — | US | disclosed |
| US-20070276036-A1 | Non-Glycosidic and Non-Peptidic Select Inhibitors, and the Use Thereof | JOHANNES GUTENBERG-UNIVERSITAT MAINZ (DE) | 2007-11-29 | — | — | US | disclosed |
| EP-1778625-A1 | NON-GLYCOSIDIC AND NON-PEPTIDIC SELECT INHIBITORS, AND THE USE THEREOF | Johannes Gutenberg-Universität Mainz (DE) | 2007-05-02 | — | — | EP | disclosed |
| WO-2006010598-A1 | NON-GLYCOSIDIC AND NON-PEPTIDIC SELECT INHIBITORS, AND THE USE THEREOF | Johannes Gutenberg-Universität Mainz (DE) | 2006-02-02 | — | — | WO | disclosed |
| US-5216173-A | Curing agents for epoxy resins; polyimides | HENKEL RESEARCH CORPORATION (US) | 1993-06-01 | — | — | US | disclosed |
| WO-1991001307-A2 | N-CYANOIMIDES AND PROCESS FOR THEIR PREPARATION AND USES THEREOF | HENKEL RESEARCH CORPORATION (US) | 1991-02-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070276036-A1 | Non-Glycosidic and Non-Peptidic Select Inhibitors, and the Use Thereof | VCAM1, ICAM1, SELPLG | CA1 1636/4885CA2 3425/4885CA12 2491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.